Trial Profile
A Double-Blind, Placebo-Controlled, Multicenter Trial to Study the Efficacy and Tolerability of MK0663/Etoricoxib in the Treatment of Pain After Abdominal Hysterectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Organon
- 27 Jun 2012 Results published in Current Medical Research and Opinion.
- 31 Mar 2012 Additional location (Ireland) added as reported by European Clinical Trials Database record.
- 31 Mar 2012 Planned number of patients changed from 396 to 432 as reported by European Clinical Trials Database record.